Andere Sprachen Celgene

Aktien

881244

CELG

Verzögert Nasdaq Andere Börsenplätze 22:00:00 20.11.2019			% 5 Tage	% 1. Jan.
108,2 ^USD	+0,10 %		-1,97 %	+68,89 %

2023	Sutro Biopharma, Inc. erhält eine Kündigung von Celgene Corporation	CI
2020	Amgen unterzeichnet Lizenzvereinbarung mit Medicines Development for Global Health	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	14.06.23
BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)	28.02.23
Not What The Doctor Ordered: Authorisation Application Withdrawn For Pharma Patent Settlement In Australia	25.08.22
Authorisation request for proposed settlement between pharmaceutical companies withdrawn	29.07.22
BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)	24.02.22
Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	08.09.21
Celgene : Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid®)	04.08.21
Besra Gold Inc: Announces Lodgment of Replacement Prospectus & Adjournment of Note Holder Meeting	09.07.21
Celgene Corporation Will Grant Sun Pharmaceutical Industries Limited A License to Celgene's Patents Required to Manufacture and Sell Certain Limited Quantity	22.06.21
Celgene : Rocket docket pharma patent litigation taking off in Australia and other emerging trends	14.04.21
DGAP-WpÜG: Tender Offer / Target company: ; Bidder: qqqqq	07.04.21
Cadila Healthcare Limited : - Zydus Announces Settlement of Patent Litigation for Generic Revlimid in U.S.	25.03.21
Leonteq becomes new issuer on BX Swiss – “deriBX”	25.03.21
BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)	23.02.21
Bristol Myers Squibb : and Celgene Issue Notices of Redemption and Partial Redemption of Certain of Their Senior Notes at 'Make Whole' Prices	23.02.21
Celgene Corporation Issues Notice of Redemption of Notes	23.02.21
Bristol-Myers Squibb Company and Celgene Corporation Announce Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion	04.02.21
Ikena Oncology, Inc. announced that it has received $120 million in funding from a group of investors	05.01.21
Amgen : Signs Licensing Agreement With Medicines Development for Global Health	22.12.20
Bristol Myers Squibb : Q3 Results Beat Estimates; Raises 2020 EPS Outlook	05.11.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Celgene

Aktien

881244

CELG

Andere Sprachen

Filter